Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Share-based Compensation: 2009-2024

Historic Share-based Compensation for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $144.0 million.

  • UNITED THERAPEUTICS's Share-based Compensation fell 6.24% to $39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.7 million, marking a year-over-year increase of 1.57%. This contributed to the annual value of $144.0 million for FY2024, which is 268.29% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Share-based Compensation stood at $144.0 million for FY2024, which was up 268.29% from $39.1 million recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Share-based Compensation high stood at $163.8 million for FY2020, and its period low was $39.1 million during FY2023.
  • Moreover, its 3-year median value for Share-based Compensation was $106.8 million (2022), whereas its average is $96.6 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 63.39% in 2023, then soared by 268.29% in 2024.
  • Over the past 5 years, UNITED THERAPEUTICS's Share-based Compensation (Yearly) stood at $163.8 million in 2020, then declined by 15.45% to $138.5 million in 2021, then decreased by 22.89% to $106.8 million in 2022, then crashed by 63.39% to $39.1 million in 2023, then surged by 268.29% to $144.0 million in 2024.